|
Primary Care Annual Topic
Index 2005
[ Topic | Author ]
Adolescent sexual health
Depot medroxyprogesterone acetate injectable contraception in adolescents: reassuring data regarding skeletal health. Aug:10-11
Teenagers and sex: delaying sexual debut. May:29-35
back to top
Alternative & complementary medicine
Bioidentical hormones: separating science from marketing. Oct:23-24
Depression during pregnancy. Aug:18-23
A dietary prescription for menopause and beyond. May:36-40
Hyperlipidemia: nutritional, botanical, and life-style influences. Jan:41-45
back to top
Autoimmune disorders
Systemic sclerosis: symptoms, diagnosis, and treatment. Feb:8-12
back to top
Breast-feeding
Physician breast-feeding education: a regional assessment. Jan:24-30
back to top
Cancer
Breast cancer risk reduction. Oct:13-16
Breast cancer screening for primary care physicians. Feb:20-26
Breast imaging update: mammography, ultrasonography, and magnetic resonance imaging. Mar:10-15
Coffee/caffeine consumption and womenÕs health. Apr:32-36
My most memorable moment: despite our best efforts. Dec:27-28
Postmenopausal hormone therapy: clarifying the role. Feb:44-45
The role of aromatase inhibitors in breast cancer therapy. Jun:21-26
Update on cervical cancer. May:11-16,28
back to top
Cardiovascular disorders
Coffee/caffeine consumption and womenÕs health. Apr:32-36
Combination oral contraceptives and migraine: is there an increased risk for ischemic stroke? Apr:37-40
Hyperlipidemia: nutritional, botanical, and life-style influences. Jan:41-45
Lyme disease in women: recognition, treatment, and prevention. Oct:38-44
Noninvasive testing for coronary artery disease in women. Dec:21-26
Nonsteroidal anti-inflammatory drugs: understanding the risks and benefits. Feb:13-19,33
Polycystic ovary syndrome in primary care. May:24-28
Postmenopausal hormone therapy: clarifying the role. Feb:44-45
Systemic sclerosis: symptoms, diagnosis, and treatment. Feb:8-12
Update: hypertension in pregnancy. Feb:28-33
Update on hypertension in women. Mar:37-42
The value of C-reactive protein in the clinical assessment of cardiovascular disease risk. Jun:11-16
Women, cardiovascular disease, and screening for type 2 diabetes. Apr:10-14
back to top
Continuing medical education (CME)
Epidemiology and characteristics of menstrual migraine: too much pain for too long. Dec:4-7[test 15-16]
Introduction [menstrual migraine CME supplement]. Dec(suppl):3,7[test 15-16]
Lyme disease in women: recognition, treatment, and prevention. Oct:38-44[test 45-46]
Multiple sclerosis and the female patient, part 1: characterizing the disease process. May:41-46[test 47-48]
Multiple sclerosis and the female patient, part 2: clinical manifestations and symptomatic treatment strategies. Jun:45-50[test 50-51]
The need for early recognition and treatment of osteoporosis to prevent fractures. Jan:9-15[test 47-48]
Osteoarthritis of the knee in women. Aug:40-44[test 45-46]
The pathophysiology and diagnosis of menstrual migraine. Dec(suppl):8-10[test 15-16]
Pharmacologic treatment of overactive bladder: review and comparison. Mar:16-21[test 49-50]
A practical guide to thyroid disease in women. Dec:38-46[test 47-48]
Strategies for menstrual migraine prevention and treatment. Dec(suppl):11-14[test 15-16]
Systemic sclerosis: symptoms, diagnosis, and treatment. Feb:8-12[test 47-48]
Update on vulvovaginal candidiasis. Apr:25-31[test 43-44]
back to top
Contraception and contraceptives
Another contraceptive choice: the single-rod implant. Feb:38-43
Combination oral contraceptives and migraine: is there an increased risk for ischemic stroke? Apr:37-40
Contraception in the perimenopausal woman. Aug:26-30
Depot medroxyprogesterone acetate injectable contraception in adolescents: reassuring data regarding skeletal health. Aug:10-11
Educating tomorrowÕs physicians in reproductive health. Dec:34-36
Family planning for obese women: challenges and opportunities. Oct:34-37
Fertility changes during perimenopause. Dec:19-20
Polycystic ovary syndrome in primary care. May:24-28
Research in male contraception. Jun:28-31
Risk factors for cholelithiasis in women. Jan:35-40
Strategies for menstrual migraine prevention and treatment. Dec(suppl):11-14
back to top
Dermatologic disorders
Lyme disease in women: recognition, treatment, and prevention. Oct:38-44
Systemic sclerosis: symptoms, diagnosis, and treatment. Feb:8-12
back to top
Diabetes
Coffee/caffeine consumption and womenÕs health. Apr:32-36
Diagnosis and management of diabetic peripheral neuropathic pain. Oct:27-33
Fine-tuning physiologic insulin replacement therapy via office downloading of home blood glucose monitoring data. Mar:29-36
Update on vulvovaginal candidiasis. Apr:25-31
Women, cardiovascular disease, and screening for type 2 diabetes. Apr:10-14
back to top
Diagnostic guidelines/tools
Breast imaging update: mammography, ultrasonography, and magnetic resonance imaging. Mar:10-15
Lyme disease in women: recognition, treatment, and prevention. Oct:38-44
Noninvasive testing for coronary artery disease in women. Dec:21-26
Update on hypertension in women. Mar:37-42
Update on vulvovaginal candidiasis. Apr:25-31
back to top
Diet
Physical activity and young adult women: maximizing benefit, minimizing risk. Jun:40-44
back to top
Editorials
At least Gregor Samsa knew he was an insect: a survival guide for physicians who care for female patients. Aug:11-12
Depot medroxyprogesterone acetate injectable contraception in adolescents: reassuring data regarding skeletal health. Aug:10-11
Evidence-based clinical guidelines are grandÑor are they? Dec:10-11
Family practice and the female patient. Mar:8
Learning from the service experts. Jan:7-8
Liability reform should be an access issue, not a money issue. Apr:8-9
The obesity epidemic: itÕs spreading. Feb:7
Polypharmacy: plague or panacea? Jun:9-10
Why wonÕt patients do what theyÕre told? May:9-10
back to top
Endocrinologic disorders
A practical guide to thyroid disease in women. Dec:38-46
back to top
Evidence-based medicine
Evidence-based clinical guidelines are grandÑor are they? Dec:10-11
back to top
Exercise
Osteoarthritis of the knee in women. Aug:40-44
Physical activity and young adult women: maximizing benefit, minimizing risk. Jun:40-44
Risk factors for cholelithiasis in women. Jan:35-40
back to top
Gastroenterological disorders
Systemic sclerosis: symptoms, diagnosis, and treatment. Feb:8-12
back to top
Gastrointestinal disorders
Risk factors for cholelithiasis in women. Jan:35-40
Serotonergic agents in the treatment of irritable bowel syndrome: a safety review. Dec:12-16
back to top
Gender issues
Gender differences in posttraumatic stress disorder. Mar:43-48
Health issues relating to women in the armed forces during and after deployment: a review. May:18-22
back to top
Genetics
My most memorable moment: despite our best efforts. Dec:27-28
back to top
Gynecologic disorders
Health issues relating to women in the armed forces during and after deployment: a review. May:18-22
Novel treatments for polycystic ovary syndrome. Dec:29-33
An overview of female infertility. Jan:16-23,40
Polycystic ovary syndrome in primary care. May:24-28
Update on cervical cancer. May:11-16,28
Vaginal atrophy: clinical evaluation and management. Apr:41-42
back to top
Headache
Combination oral contraceptives and migraine: is there an increased risk for ischemic stroke? Apr:37-40
Epidemiology and characteristics of menstrual migraine: too much pain for too long. Dec:4-7
Introduction [menstrual migraine CME supplement]. Dec(suppl):3,7
The pathophysiology and diagnosis of menstrual migraine. Dec(suppl):8-10
Strategies for menstrual migraine prevention and treatment. Dec(suppl):11-14
back to top
Hormones and hormone therapy
Bioidentical hormones: separating science from marketing. Oct:23-24
Depot medroxyprogesterone acetate injectable contraception in adolescents: reassuring data regarding skeletal health. Aug:10-11
Memory complaints. Aug:24-25
Menopausal hormone therapy: the symptomatic patient. Apr:16-22
Postmenopausal hormone therapy: clarifying the role. Feb:44-45
Risk factors for cholelithiasis in women. Jan:35-40
The role of aromatase inhibitors in breast cancer therapy. Jun:21-26
Strategies for menstrual migraine prevention and treatment. Dec(suppl):11-14
Vaginal atrophy: clinical evaluation and management. Apr:41-42
back to top
Infections
Lyme disease in women: recognition, treatment, and prevention. Oct:38-44
Update on vulvovaginal candidiasis. Apr:25-31
back to top
Infertility
An overview of female infertility. Jan:16-23,40
Polycystic ovary syndrome in primary care. May:24-28
back to top
Laser therapy
Endoluminal varicose vein therapy. Aug:31-32,37-39
back to top
Magnetic resonance imaging
Breast imaging update: mammography, ultrasonography, and magnetic resonance imaging. Mar:10-15
back to top
Mammography
Breast imaging update: mammography, ultrasonography, and magnetic resonance imaging. Mar:10-15
back to top
Medical coding
Depression during pregnancy. Aug:18-23
Lyme disease in women: recognition, treatment, and prevention. Oct:38-44
Pharmacologic treatment of overactive bladder: review and comparison. Mar:16-21
A practical guide to thyroid disease in women. Dec:38-46
Sexually transmitted infections in women: an overview. Jun:34-39
Update on vulvovaginal candidiasis. Apr:25-31
back to top
Medical training
Educating tomorrowÕs physicians in reproductive health. Dec:34-36
back to top
Menopause
Bioidentical hormones: separating science from marketing. Oct:23-24
Bisphosphonate dosing preferences in women with postmenopausal osteoporosis: a study. Aug:12-17
Contraception in the perimenopausal woman. Aug:26-30
A dietary prescription for menopause and beyond. May:36-40
Fertility changes during perimenopause. Dec:19-20
Fractures and falls: minimizing the risks. Jun:32-33
Loss of sexual desire and menopause: prevalence, causes, and impact on quality of life. Mar:22-28
Memory complaints. Aug:24-25
Menopausal hormone therapy: the symptomatic patient. Apr:16-22
The need for early recognition and treatment of osteoporosis to prevent fractures. Jan:9-15
Postmenopausal hormone therapy: clarifying the role. Feb:44-45
The role of aromatase inhibitors in breast cancer therapy. Jun:21-26
Vaginal atrophy: clinical evaluation and management. Apr:41-42
back to top
Menstruation
Epidemiology and characteristics of menstrual migraine: too much pain for too long. Dec:4-7
Introduction [menstrual migraine CME supplement]. Dec(suppl):3,7
The pathophysiology and diagnosis of menstrual migraine. Dec(suppl):8-10
Physical activity and young adult women: maximizing benefit, minimizing risk. Jun:40-44
Polycystic ovary syndrome in primary care. May:24-28
Strategies for menstrual migraine prevention and treatment. Dec(suppl):11-14
back to top
Magnetic resonance imaging
Multiple sclerosis and the female patient, part 1: characterizing the disease process. May:41-46
back to top
Musculoskeletal disorders
Lyme disease in women: recognition, treatment, and prevention. Oct:38-44
back to top
Neurologic disorders
Lyme disease in women: recognition, treatment, and prevention. Oct:38-44
Multiple sclerosis and the female patient, part 1: characterizing the disease process. May:41-46
Multiple sclerosis and the female patient, part 2: clinical manifestations and symptomatic treatment strategies. Jun:45-50
back to top
Nutrition
Coffee/caffeine consumption and womenÕs health. Apr:32-36
A dietary prescription for menopause and beyond. May:36-40
Risk factors for cholelithiasis in women. Jan:35-40
back to top
Obesity
Bisphosphonate dosing preferences in women with postmenopausal osteoporosis: a study. Aug:12-17
Family planning for obese women: challenges and opportunities. Oct:34-37
The obesity epidemic: itÕs spreading. Feb:7
Osteoarthritis of the knee in women. Aug:40-44
Physical activity and young adult women: maximizing benefit, minimizing risk. Jun:40-44
Polycystic ovary syndrome in primary care. May:24-28
Risk factors for cholelithiasis in women. Jan:35-40
back to top
Obstetrics and gynecology
Osteoarthritis of the knee in women. Aug:40-44
back to top
Osteoarthritis
Osteoarthritis of the knee in women. Aug:40-44
back to top
Osteoporosis
Fractures and falls: minimizing the risks. Jun:32-33
The need for early recognition and treatment of osteoporosis to prevent fractures. Jan:9-15
Physical activity and young adult women: maximizing benefit, minimizing risk. Jun:40-44
Postmenopausal hormone therapy: clarifying the role. Feb:44-45
back to top
Pain
Diagnosis and management of diabetic peripheral neuropathic pain. Oct:27-33
back to top
Patient education
What you should know aboutÉ
Breast cancer. Oct:49-50
C-reactive protein. Jun:53-54
Diet and menopause. May:49-50
Infertility. Jan:49-50
Overactive bladder. Mar:51-52
Scleroderma. Feb:48-49
Thyroid disease. Dec:49-50
Varicose veins. Aug:47-48
Yeast infections. Apr:45-46
back to top
Pharmacotherapy
Bioidentical hormones: separating science from marketing. Oct:23-24
Bisphosphonate dosing preferences in women with postmenopausal osteoporosis: a study. Aug:12-17
Breast cancer risk reduction. Oct:13-16
Depression during pregnancy. Aug:18-23
Diagnosis and management of diabetic peripheral neuropathic pain. Oct:27-33
Gender differences in posttraumatic stress disorder. Mar:43-48
Lyme disease in women: recognition, treatment, and prevention. Oct:38-44
Multiple sclerosis and the female patient, part 1: characterizing the disease process. May:41-46
The need for early recognition and treatment of osteoporosis to prevent fractures. Jan:9-15
Nonsteroidal anti-inflammatory drugs: understanding the risks and benefits. Feb:13-19,33
Novel treatments for polycystic ovary syndrome. Dec:29-33
Osteoarthritis of the knee in women. Aug:40-44
Pharmacologic treatment of overactive bladder: review and comparison. Mar:16-21
Polypharmacy: plague or panacea? Jun:9-10
The role of aromatase inhibitors in breast cancer therapy. Jun:21-26
Serotonergic agents in the treatment of irritable bowel syndrome: a safety review. Dec:12-16
Strategies for menstrual migraine prevention and treatment. Dec(suppl):11-14
Update: hypertension in pregnancy. Feb:28-33
Update on hypertension in women. Mar:37-42
back to top
Physician/Patient Relationship
Family practice and the female patient. Mar:8
Screening patients for nonadherence. Feb:34-37
Why wonÕt patients do what theyÕre told? May:9-10
YouÕve got e-mail:physician-patient electronic communication. Jan:31-34
back to top
Pregnancy
Coffee/caffeine consumption and womenÕs health. Apr:32-36
Depression during pregnancy. Aug:18-23
Family planning for obese women: challenges and opportunities. Oct:34-37
Health issues relating to women in the armed forces during and after deployment: a review. May:18-22
Multiple sclerosis and the female patient, part 2: clinical manifestations and symptomatic treatment strategies. Jun:45-50
A practical guide to thyroid disease in women. Dec:38-46
Risk factors for cholelithiasis in women. Jan:35-40
Teenagers and sex: delaying sexual debut. May:29-35
Update: hypertension in pregnancy. Feb:28-33
Update on hypertension in women. Mar:37-42
back to top
Psychiatric disorders
Depression during pregnancy. Aug:18-23
Gender differences in posttraumatic stress disorder. Mar:43-48
Health issues relating to women in the armed forces during and after deployment: a review. May:18-22
Multiple sclerosis and the female patient, part 2: clinical manifestations and symptomatic treatment strategies. Jun:45-50
back to top
Psychological issues
Gender differences in posttraumatic stress disorder. Mar:43-48
Health issues relating to women in the armed forces during and after deployment: a review. May:18-22
Loss of sexual desire and menopause: prevalence, causes, and impact on quality of life. Mar:22-28
Memory complaints. Aug:24-25
Multiple sclerosis and the female patient, part 2: clinical manifestations and symptomatic treatment strategies. Jun:45-50
back to top
Pulmonary disorders
Systemic sclerosis: symptoms, diagnosis, and treatment. Feb:8-12
back to top
Regulatory/Reform issues
At least Gregor Samsa knew he was an insect: a survival guide for physicians who care for female patients. Aug:11-12
Liability reform should be an access issue, not a money issue. Apr:8-9
back to top
Rheumatological disorders
Systemic sclerosis: symptoms, diagnosis, and treatment. Feb:8-12
back to top
Screening
Breast cancer screening for primary care physicians. Feb:20-26
Breast imaging update: mammography, ultrasonography, and magnetic resonance imaging. Mar:10-15
Diagnosis and management of diabetic peripheral neuropathic pain. Oct:27-33
Polypharmacy: plague or panacea? Jun:9-10
Screening patients for nonadherence. Feb:34-37
Sexually transmitted infections in women: an overview. Jun:34-39
Update on cervical cancer. May:11-16,28
The value of C-reactive protein in the clinical assessment of cardiovascular disease risk. Jun:11-16
Women, cardiovascular disease, and screening for type 2 diabetes. Apr:10-14
back to top
Sexual health
Loss of sexual desire and menopause: prevalence, causes, and impact on quality of life. Mar:22-28
Multiple sclerosis and the female patient, part 2: clinical manifestations and symptomatic treatment strategies. Jun:45-50
Teenagers and sex: delaying sexual debut. May:29-35
back to top
Sexually transmitted infections (STIs)
Sexually transmitted infections in women: an overview. Jun:34-39
Teenagers and sex: delaying sexual debut. May:29-35
back to top
Surgery
Breast cancer risk reduction. Oct:13-16
My most memorable moment: despite our best efforts. Dec:27-28
Osteoarthritis of the knee in women. Aug:40-44
back to top
Technology
YouÕve got e-mail:physician-patient electronic communication. Jan:31-34
back to top
Ultrasonography
Breast cancer screening for primary care physicians. Feb:20-26
Breast imaging update: mammography, ultrasonography, and magnetic resonance imaging. Mar:10-15
Endoluminal varicose vein therapy. Aug:31-32,37-39
back to top
Urogynecology
Pharmacologic treatment of overactive bladder: review and comparison. Mar:16-21
back to top
Urologic disorders
Health issues relating to women in the armed forces during and after deployment: a review. May:18-22
Multiple sclerosis and the female patient, part 2: clinical manifestations and symptomatic treatment strategies. Jun:45-50
Pharmacologic treatment of overactive bladder: review and comparison. Mar:16-21
back to top
|
